Microsoft Corporation (MSFT)

212.23
4.10 1.90
NASDAQ
Prev Close 216.35
Day Low/High 210.93 / 215.70
52 Wk Low/High 131.83 / 217.64
Exchange NASDAQ
Shares Outstanding 7567.65B
Market Cap 1637.26B
Div & Yield N.A. (N.A)

Latest News

Deal or No Deal, the Rally Narrows, Trump's Pen, Debating Datadog: Market Recon

Deal or No Deal, the Rally Narrows, Trump's Pen, Debating Datadog: Market Recon

It would be better if Jobs Day became Deal Day, and can Congress get its act together before the president acts instead?

They're Partying Like It's 1999

* In the extremus...   "Say say Two-thousand-zero-zero party over Oops out of time So tonight I'm gonna party like it's 1999" - Prince, Party Like It's 1999 The outperformance and bifucation of FAANG plus Microsoft is now moving to the extreme.  In ...

TikTok Can Fill a Hole in Microsoft's Consumer Portfolio -- If Handled Right

TikTok Can Fill a Hole in Microsoft's Consumer Portfolio -- If Handled Right

TikTok could give Microsoft the kind of large-scale consumer mobile footprint it has wanted for years. And Microsoft in turn has some assets that TikTok could find useful.

Jim Cramer: This Is Where to Put Your Cash as Covid Surges

Jim Cramer: This Is Where to Put Your Cash as Covid Surges

Instead of scratching your head and saying the market defies logic, look to the Cramer Covid-19 Index.

Bitcoin and Biotech on My Mind as Defiant Bears Get Crushed

Bitcoin and Biotech on My Mind as Defiant Bears Get Crushed

Liquidity, FOMO and a short squeeze are driving market action.

Microsoft Dances With TikTok

Microsoft Dances With TikTok

Monday's action forces some changes, and here's my plan for MSFT.

TikTok Stokes Trump's Nationalistic Fervor for No Good Reason

TikTok Stokes Trump's Nationalistic Fervor for No Good Reason

Are U.S. politicians really rocking to Lil Uzi Vert's Futsal Shuffle, and worried their efforts will fall into Chinese hands?

Ozzy and I Don't Know, Hare-Raising Tale, Enter the Dog Days: Market Recon

Ozzy and I Don't Know, Hare-Raising Tale, Enter the Dog Days: Market Recon

Plus, Russia could provide a real-time clinical trial of a coronavirus vaccine.

Grotesque GDP, So Much for Rotation, Amazon Goes Wild: Market Recon

Grotesque GDP, So Much for Rotation, Amazon Goes Wild: Market Recon

Plus, it could be quite a while before the labor market can absorb all those people who are out of jobs.

Get Ready for an Earnings Extravaganza

Get Ready for an Earnings Extravaganza

Huge earnings news and economic reports will drive the indices while aggressive speculative trading continues in smaller stocks.

This Is Likely a Good Time to Dial Things Back and Observe the Action

This Is Likely a Good Time to Dial Things Back and Observe the Action

Anyone playing the guessing game into earnings is rolling the dice.

On the Short Side

As mentioned, I am offering and on the short side.

I Plan To Add to My Apple and Microsoft Shorts This Morning

My two Trades of the Week, delivered yesterday - was to short and .  AAPL was -$6.23 and MSFT was -$1.83 lower in the trading session.  With Nasdaq futures +50 handles in pre-market trading, I plan to add to my shorts of these two stocks on any stre...

Jim Cramer: I Care About What's Left of American Success in a Globalized Economy

Jim Cramer: I Care About What's Left of American Success in a Globalized Economy

These House antitrust hearings are ridiculous given that the companies on the hot seats are about the best thing we have going for us.

The Tech Names Run Out of Energy

The Tech Names Run Out of Energy

Selling is broadening and speculative trading is narrowing, but it's tough to read too much into either yet.

Two Trades of the Week - Shorting AAPL and MSFT

I plan to step up my Apple and Microsoft short positions today and/or over the next few days.  My rationale is that multiple revaluations higher has meaningfully moved both stocks - a condition that often puts equities into a vulnerable and overboug...

It Makes Sense to Diversify Away from High-Beta Names

It Makes Sense to Diversify Away from High-Beta Names

And there is a particular Brazilian ETF that is worth exploring if you want to take advantage of rising commodity prices and the falling U.S. dollar.

Tops Are Processes...

* Bottoms are events * There is no change in my ursine market view and game plan  "With the possible exception of things like box scores, race results, and stock market tabulations, there is no such thing as Objective Journalism. The phrase itself i...

The Uptrend Continues but Headline Risk Is Lurking

The Uptrend Continues but Headline Risk Is Lurking

Precious metals reverse on a strong dollar, which should trigger some rotational action.

Now's the Time for Companies to Mix It Up

Now's the Time for Companies to Mix It Up

Firms should be using their high stock price to grab other businesses to expand, so they're ready when things return to normal.

Looking for Opportune Entry Points in 3 Dominant Big-Cap Names

Looking for Opportune Entry Points in 3 Dominant Big-Cap Names

We're tracking potential buy setups in Lululemon Athletica, Microsoft and Netflx.

3 Big News Events This Week Will Determine the Market's Next Move

3 Big News Events This Week Will Determine the Market's Next Move

Monetary policy, fiscal policy, and major earnings news are all on the docket.

A Weaker Dollar, Heavy Earnings Week, Add to Amazon but Not Apple?

A Weaker Dollar, Heavy Earnings Week, Add to Amazon but Not Apple?

What has changed significantly has been the value of the U.S. dollar relative to peer currencies.

Kass: 10 Key Factors That Could Send Us Into a Bear Market in 2020

Kass: 10 Key Factors That Could Send Us Into a Bear Market in 2020

The wise man considers the 'ifs' - the contrary - and constantly evaluates, and often rallies against, 'group stink'.

This Market Rotation Is No One-Hit Wonder

This Market Rotation Is No One-Hit Wonder

Will next week bring a resumption in technology leadership, further rotation, or broader selling?

FATMAAN's Diet Is Healthy for This Market

FATMAAN's Diet Is Healthy for This Market

I'm doing some dip buying amid weakness in large-cap tech stocks.

Corbus Pharmaceuticals Is an Example of How I'm Playing an Uncertain Market

Corbus Pharmaceuticals Is an Example of How I'm Playing an Uncertain Market

CRBP has topline Phase 3 data for its primary compound Lenabasum for Systemic Sclerosis due out this summer.

Expect the Unexpected as it All Starts Somewhere

* Will the Embassy tit for tat be the nail in the market (that many haven't been looking at) and be the catalyst for the market's relentless advance from March to end? * Yesterday's outside day may have been a dark moment in time for the markets and...